Results 131 to 140 of about 22,199 (155)

The Committee for Orphan Medicinal Products of the EMEA has granted orphan drug status to maribavir

Inpharma Weekly, 2007
openaire   +1 more source

Polymer–drug conjugate therapeutics: advances, insights and prospects

Nature Reviews Drug Discovery, 2018
Iriny Ekladious, Yolonda L Colson, Mark Grinstaff   +2 more
exaly  

A comprehensive map of molecular drug targets

Nature Reviews Drug Discovery, 2016
Rita Santos, Oleg Ursu, Anna Gaulton
exaly  

Opportunities and challenges in phenotypic drug discovery: an industry perspective

Nature Reviews Drug Discovery, 2017
Fabien Vincent, Jonathan A Lee, Marco Prunotto   +2 more
exaly  

Evergreening exclusive rights in pharmaceutical products: the case of SPCs, paediatric extensions and orphan drugs

2022
openaire   +1 more source

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

The Committee for Orphan Medicinal Products of the European Medicines Agency has granted PTC 124 [PTC Therapeutics] orphan drug status

Inpharma Weekly, 2005
openaire   +1 more source

Subcellular targeting strategies for drug design and delivery

Nature Reviews Drug Discovery, 2010
Lawrence Rajendran, Hans-Joachim Knölker   +1 more
exaly  

1989 annual survey--133 orphan drug products.

Hospital pharmacy, 1990
openaire   +1 more source

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
exaly